Metabolic effects of liver transplantation in cirrhotic patients

Journal of Clinical Investigation

Volumn 99, Issue 4, 1997, Pages 692-700

  Luzi, Livio ^d,e   Perseghin, Gianluca ^a   Regalia, Enrico ^b   Sereni, Lucia Piceni ^a   Battezzati, Alberto ^a   Baratti, Dario ^b   Bianchi, Elda ^a   Terruzzi, Ileana ^a   Hilden, Hannele ^c   Groop, Leif C ^c   Pulvirenti, Andrea ^b   Taskinen, Marja Riitta ^c   Gennari, Leandro ^b   Mazzaferro, Vincenzo ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b NATIONAL CANCER INSTITUTE   (Italy)

^c UNIVERSITY OF HELSINKI   (Finland)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

FFA turnover; glucose turnover; insulin resistance; leucine turnover; liver transplantation

Indexed keywords

BRANCHED CHAIN AMINO ACID; GLUCOSE; INSULIN; LEUCINE;

ADULT; AMINO ACID METABOLISM; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; GLUCOSE HOMEOSTASIS; HUMAN; INSULIN RESISTANCE; LIVER CIRRHOSIS; LIVER METABOLISM; LIVER TRANSPLANTATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL;

EID: 0031034472     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119213     Document Type: Article

References (59)

1. Zoli, M., G. Marchesini, C. Dondi, G.P. Bianchi, and E. Pisi. 1972. Myofibrillar protein catabolic rates in cirrhotic patients with and without muscle wasting. Clin. Sci. 62:683-686.
2. O'Keefe, S.J.D., R.R. Abraham, M. Davis, and R. Williams. 1981. Protein turnover in acute and chronic liver disease. Acta. Chir. Scand. 507:91-101.
3. Morgan, M.Y., A.W. Marshall, J.P. Milsom, and S. Sherlock. 1982. Plasma amino acid pattern in liver disease. Gut. 23:362-370.
4. Vilstrup, H., D. Bucher, B. Krag, and S.E. Damgard. 1982. Elimination of infused amino acids from plasma of control subjects and of patients with cirrhosis of the liver. Eur. J. Clin. Invest. 12:197-202.
5. Cavallo-Perin, P., M. Cassader, C. Bozzo, P. Nuccio, A.M. Dall' Omo, M. Marucci, G. Pagano. 1985. Mechanism of insulin resistance in human liver cirrhosis. J. Clin. Invest. 75:1659-1665.
6. Petrides, A.S., L.C. Groop, C.A. Riely, and R.A. De Fronzo. 1988. Effect of physiologic hyperinsulinemia on glucose and lipid metabolism in cirrhosis. J. Clin. Invest. 88:561-570.
7. Starzl, T.E., A.J. Demeter, and D. van Thiel. 1989. Liver transplantation. N. Engl. J. Med. 321:1014-1022.
8. Bismuth, H., D. Castaing, B.G. Ericzon, J.B. Otte, K. Rolles, B. Ringe, and M. Sloof. 1987. Hepatic transplantation in Europe. Lancet. ii:674-676.
9. Pennington, J.C. 1989. Quality of life following liver transplantation. Transplant. Proc. 21:3514-3516.
10. Mazzaferro, V., E. Regalia, R. Doci, S. Andreola, A. Pulvirenti, F. Bozzetti, F. Montalto, M. Ammatuna, A. Morabito, and L. Gennari. 1996. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N. Engl. J. Med. 334:693-699.
11. Abumrad, N.N., D. Rabin, M.P. Diamond, and W.W. Lacy. 1981. Use of an heated superficial vein as an alternative site for the measurement of amino acid concentrations and for the study of glucose and alanine kinetics in man. Metab. Clin. Exp. 30:936-940.
12. Cobelli, C., M.P. Saccomani, P. Tessari, G. Biolo, L. Luzi, and D.E. Matthews. 1991. Compartmental model of leucine kinetics in humans. Am. J. Physiol. 26:E539-E550.
13. Luzi, L., P. Castellino, D.C. Simonson, A.S. Petrides, and R.A. De Fronzo. 1990. Leucine metabolism in IDDM. Role of insulin and substrate availability. Diabetes. 39:38-48.
14. Luzi, L., A. Battezzati, G. Perseghin, E. Bianchi, I. Terrazzi, D. Spotti, S. Vergani, A. Secchi, E. La Rocca, G. Ferrari, et al. 1994. Combined pancreas and kidney transplantation normalizes protein metabolism in insulin-dependent diabetic-uremic patients. J. Clin. Invest. 93:1948-1958.
15. Coward, W.A., S.A. Parkinson, and P.R. Murgatroyd. 1989. Body composition measurements for nutrition research. Nutr. Res. Rev. 1:115-124.
16. Luzi, L, B.J. Hering, C. Socci, G. Raptis, A. Battezzati, I. Terruzzi, L. Falqui, H. Brandhorst, D. Brandhorst. E. Regalia, et al. 1996. Metabolic effects of successful intraportal islet transplantation in insulin-dependent diabetes mellitus. J. Clin. Invest. 97:11:2611-2618.
17. Miles, J.R., J. Glasscock, J. Aikens, J. Gerich, and M. Haymond. 1983. A microfluorometric method for the determination of free fatty acids in plasma. J. Lipid. Res. 24:96-99.
18. Groop, L.C., R.C. Bonadonna, S. Del Prato, K. Ratheiser, K. Zyck, E. Ferranini and F.A. DeFronzo. 1989. Glucose and free fatty acid metabolism in non-insulin dependent diabetes mellitus. Evidence for multiple sites of insulin resistance. J. Clin. Invest. 84:205-213.
19. Luzi, L., A. Secchi, F. Facchini, A. Battezzati, C. Staudacher, D. Spotti, R. Castoldi, G. Ferrari, V. Di Carlo, and G. Pozza. 1990. Reduction of insulin resistance by combined kidney-pancreas transplantation in type 1 (insulin-dependent) diabetic patients. Diabetologia. 33:549-556.
20. 13C] bicarbonate kinetics in humans: intra vs interindividual variations. Am. J. Physiol. 245:R190-R202.
21. Schwenk, W.F., I.B. Beaufrere, and M.W. Haymond. 1981. Use of reciprocal pool specific activities to model leucine metabolism in man. Am. J. Physiol. 240:E630-E639.
22. Steele, R. 1959. Influence of glucose loading and of injected insulin on hepatic glucose output. Annu. N.Y. Acad. Sci. 82:420-430.
23. Frayn, K.N. 1983. Calculation of substrate oxidation rates in vivo from gaseous exchange. J. Appl. Physiol. 55:628-634.
24. Shanbhogue, R.L.K., B.R. Bistrian, K. Lakshman, L. Crosby, S. Swenson, D. Wagner, R.L. Jenkins, and G.L. Blackburn. 1987. Whole-body leucine, phenylalanine and tyrosine kinetics in end-stage liver disease before and after hepatic transplantation. Metab. Clin. Exp. 36:1047-1053.
25. McCullough, A.J., and T. Glamour. 1993. Differences in amino acid kinetics in cirrhosis. Gastroenterology. 104:1858-1865.
26. Petrides, A.S., L. Luzi, A. Reuben, C. Riely, and R.A. De Fronzo. 1991. Effect of insulin and plasma amino acid concentration on leucine metabolism in cirrhosis. Hepatology. 14:432-441.
27. Morrison, W.L., I.A.D. Bouchier, J.N.A. Gibson, and M.J. Rennie. 1990. Skeletal muscle and whole-body protein turnover in cirrhosis. Clin. Sci. 78:613-619.
28. Millikan, W.J., J.M. Henderson, J.R. Galloway, W.D. Warren, D.E. Matthews, A. McGhoe, and M.H. Kutner. 1985. In vivo measurement of leucine metabolism with stable isotopes in normal subjects and in those with cirrhosis fed conventional and branched chain amino acid enriched formulations. Surgery. 98:405-412.
29. Tessari, P., G. Biolo, S. Inchiostro, R. Orlando, M. Vettore, and G. Sergi. 1993. Leucine and phenylalanine kinetics in compensated liver cirrhosis: effects of insulin. Gastroenterology. 104:1712-1721.
30. Robinson, K.A., K.P. Boggs, and M.G. Buse. 1993. Okadaic acid, insulin and denervation effects on glucose and amino acid transport and glycogen synthesis in muscle. Am. J. Physiol. 265:E36-E43.
31. Navasa, M., F. Feu, J.C. Garcia-Pagan, W. Jimenez, J. Llach, A. Rimola, J. Bosch, and J. Rodes. 1993. Hemodynamic and humoral changes after liver transplantation in patients with cirrhosis. Hepatology. 17:355-360.
32. Kjaer, M., S. Keiding, K. Engfred, K. Rasmussen, B. Sonne, P. Kirkegard, and H. Galbo. 1995. Glucose homeostasis during exercise in humans with a liver or kidney transplant. Am. J. Physiol. 268:E636-E644.
33. Castellino, P., L. Luzi, D.C. Simonson, M.W. Haymond, and R.A. De Fronzo. 1987. Effect of insulin and plasma amino acid concentrations on leucine metabolism in man. Role of substrate availability on estimates of whole body protein synthesis. J. Clin. Invest. 80:1784-1793.
34. Luzi, L, A.S. Petrides, and R.A. DeFronzo. 1993. Different sensitivity of glucose and amino acid metabolism to insulin in NIDDM. Diabetes. 42:1868-1877.
35. Castellino, P., A. Solini, L. Luzi, J. Grant-Barr, D.J. Smith, A.S. Petrides, M. Giordano, D. Carrol, and R.A. DeFronzo. 1992. Glucose and amino acid metabolism in patients in chronic renal failure. Am. J. Physiol. 262:F168-F176.
36. Tessari, P., R. Nosadini, R. Trevisan, S.I. Vigili de Kreutzenberg, S. Duner, C. Marescotti, and A. Tiengo. 1986. Defective suppression by insulin of leucine-carbon appearance and oxidation in Type 1, insulin-dependent diabetes mellitus. J. Clin. Invest. 77:1797-1804.
37. Horber, F.F., C.M. Horber-Feider, S. Krayer, W.F. Schwenk, and M.W. Haymond. 1989. Plasma reciprocal pool specific activity predicts that of intracellular free leucine for protein synthesis. Am. J. Physiol. 257:E385-E399.
38. Heslin, M.J., E. Newmann, R.F. Wolf, P.W.T. Pisters, and M.F. Brennan. 1992. Effect of hyperinsulinemia on whole body and skeletal muscle leucine carbon kinetics in humans. Am. J. Physiol. 262:E911-E918.
39. 13C] leucine infusion in man: a method for measuring human intracellular leucine tracer enrichment. Metab. Clin. Exp. 31:1105-1112.
40. McCullough, A.J., K.D. Mullen, A.S. Tavill, and S.C. Kahlan. 1992. In vivo differences between the turnover rates of leucine and leucine's keto acid in stable cirrhosis. Gastroenterology. 103:571-578.
41. MacGilchrist, A.J., and J.L. Reid. 1990. Impairment of autonomie reflexes in cirrhosis. Am. J. Gastroeterol. 85:288-282.
42. Lee, J.A., Q. Ahmed, J.E. Hines, and A.D. Burt. 1992. Disappearance of hepatic parenchimal nerves in human liver cirrhosis. Gut. 33:87-91.
43. Jaskiewicz, K., M.D. Voigt, and S.C. Robson. 1994. Distribution of hepatic nerve fibers in liver disease. Digestion. 55:247-252.
44. Pagano, G., P. Cavallo-Perin, M. Cassader, A. Bruno, A. Ozzello, P. Masciale, A.M. Dall' Omo, and B. Imbimbo. 1983. An in vivo and in vitro study of the mechanism of prednisone-induced insulin resistance in healthy subjects. J. Clin. Invest. 72:1814-1820.
45. Schevadr, E.M. 1985. The effects of cyclosporin A on the immune system. Annu. Rev. Immunol. 3:397.
46. Palestine, A.G., R.B. Nussenblatt, and C-C. Chan. 1984. Side effects of systemic cyclosporin in patients not undergoing transplantation. Am. J. Med. 77:652-656.
47. Tomas, F.N., H.N. Munro, and V.R. Young. 1979. Effect of glucocorticoid administration on the rate of muscle protein breakdown in vivo in rats, as measured by urinary excretion of N-methylhistidine. Biochem. J. 178:139-146.
48. Gillkison, S.G., S.T. Bartlett, and D.L. Cury. 1989. Synthesis-secretion coupling of insulin: effect of cyclosporin. Diabetes. 38:465-470.
49. Martin, R.J., and L.L. Bernardis. 1980. Characterization of tissue enzyme activities in rats with dorsomedial hypothalamic lesions and their sham operated controls. Physiol. Behav. 24:855-858.
50. Shimazu, T. 1981. Central nervous system regulation of liver and adipose tissue metabolism. Diabetologia. 20:343-356.
51. Shimazu, T. 1983. Reciprocal innervation of the liver: its significance in metabolic control. In Advances in Metabolic Disorders. A.J. Szabo, editor. Academic Press Inc., New York/London. 10, 355-384.
52. Lautt, W.W. 1983. Afferent and efferent neural roles in liver function. Prog. Neurobiol. 21:323-348.
53. Shimazu, T. 1987. Neuronal regulation of hepatic glucose metabolism in mammals. In Diabetes/Metabolism Reviews. R.A. DeFronzo, editor. John Wiley & Sons, New York. 3:185-206.
54. Aki, K., K. Ogawa, and A. Ichihara. 1968. Transaminase of branched chain amino acids. Purification and properties of two enzymes from rat liver. Biochim. Biophys. Acta. 159:276-284.
55. Odessey, R., and A.L. Goldberg. 1979. Leucine degradation in cell-free extracts of skeletal muscle. Biochem. J. 178:475-489.
56. Block, K.P., B.W. Heywood, M.G. Buse, and A.E. Harper. 1985. Activation of rat liver branched-chain 2-oxo-acid dehydrogenase in vivo by glucagon and adrenaline. Biochem. J. 232:593-597.
57. Luzi, L., L.C. Groop, G. Perseghin, M-R Taskinen, H. Hilden, E. Bianchi, I. Terruzzi, A.R. Dodesini, V. Di Carlo, and G. Pozza. 1996. Effect of pancreas transplantation on free fatty acid metabolism in insulin dependent diabetic uremic patients. Diabetes. 45:354-360.
58. Groop, L.C., R.C. Bonadonna, M. Shank, A.S. Petrides, and R.A. De Fronzo. 1991. Role of free fatty acids and insulin in determining free fatty acid and lipid oxidation in man. J. Clin. Invest. 87:83-89.
59. 13C nuclear magnetic spectroscopy. N. Engl. J. Med. 322:223-228.